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Abstract
In bacteria, Acyl Carrier Protein (ACP) is the central cofactor for fatty acid biosynthesis. It carries the acyl chain in elongation
and must therefore interact successively with all the enzymes of this pathway. Yet, ACP also interacts with proteins of
diverse unrelated function. Among them, the interaction with SpoT has been proposed to be involved in regulating ppGpp
levels in the cell in response to fatty acid synthesis inhibition. In order to better understand this mechanism, we screened for
ACP mutants unable to interact with SpoT in vivo by bacterial two-hybrid, but still functional for fatty acid synthesis. The
position of the selected mutations indicated that the helix II of ACP is responsible for the interaction with SpoT. This
suggested a mechanism of recognition similar to one used for the enzymes of fatty acid synthesis. Consistently, the
interactions tested by bacterial two-hybrid of ACP with fatty acid synthesis enzymes were also affected by the mutations
that prevented the interaction with SpoT. Yet, interestingly, the corresponding mutant strains were viable, and the
phenotypes of one mutant suggested a defect in growth regulation.
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Introduction
In bacteria, Acyl Carrier Protein (ACP) is the free cofactor for
type II fatty acid biosynthesis [1]. ACP is a small and acidic
protein (8–10 kDa, pI<4), which is also very abundant. It is
modified post-translationnally on a conserved Serine residue
(Serine 36 in E. coli) with a 49-phosphopantetheine group (49PP)
by the holo-ACP synthase AcpS. Intermediates of fatty acid
synthesis are constantly bound by a thioester link to the sulfhydryl
group brought by the 49PP group on ACP. As such, ACP interacts
successively with and navigates between the numerous enzymes
involved in fatty acid synthesis in order to deliver the acyl chain in
elongation [2].
All the enzymatic steps of the fatty acid synthesis cycle have
been extensively studied and are very well described [3]. In each
case, an interaction between the enzyme and ACP is required,
since acyl thioesters of ACP are the substrates of the reaction. In
order to interact with so many distinct enzymes, to enable rapid
association and dissociation, and to be able to shield or present the
fatty acid chain to the enzymes, ACP structure must be highly
flexible. Indeed, it has been shown to exist in different
conformational states, with a flexible hydrophobic cavity [4,5].
Furthermore, the specificity of recognition should not be too high,
which is reflected by relatively weak Km of association [6,7]. It has
been shown that a-helix II of ACP plays a prominent role in this
loose recognition of fatty acid synthesis enzymes [8,9]. A synthetic
peptide of 8 residues mimicking a-helix II and carrying an acyl-
thioester is even sufficient for recognition by fatty acid synthesis
enzymes [7]. This a-helix is rich in acidic residues, and is predicted
to recognize patches of hydrophobic residues surrounded by basic
residues on the surface of the enzymes [8].
Complexes and the corresponding 3D structures have been
obtained only for AcpS and FabI in interaction with ACP [10,11].
The structure of ACP in complex with the soluble STAS domain
of the inner membrane protein YchM has also been described
recently [12]. YchM is suggested to be a bicarbonate transporter
and the interaction with ACP may be important to optimize fatty
acid synthesis [12]. In addition, numerous partners of ACP were
identified by Tandem Affinity Purification [13–15]. As expected,
several enzymes involved in fatty acid or phospholipid biogenesis
that are known to interact with ACP were present among them
(such as the three keto-acyl synthases FabF, FabB, and FabH, but
also FabD, FabG, AcpS, PlsB or Aas). However, several proteins
that are not directly related to lipid metabolism (YbgC, IscS,
MukB, and SpoT) were also identified in these ACP tandem
affinity purifications. These interactions were further validated by
co-purification experiments [13,15,16] but additional studies are
still needed in order to understand their role in the cell.
We have previously characterized the interaction between ACP
and SpoT [16]. SpoT is a bifunctional enzyme, that catalyses both
hydrolysis and synthesis of (p)ppGpp, the effector of the stringent
response in bacteria [17,18]. (p)ppGpp is a global transcriptional
regulator that binds RNA polymerase and impacts transcription of
hundreds of genes. Upon nutritional starvation, (p)ppGpp level
raises and as a consequence growth is arrested, mainly through
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(p)ppGpp increase in response to a variety of starvation events,
such as glucose, iron, phosphate, or fatty acid starvation [19–22].
Both activities of SpoT (ppGpp degradation and synthesis) are
localized in the N-terminal half of the protein, and are controlled
by allosteric transition shifting the protein from one activity to the
opposite, which results in controlling (p)ppGpp level in the cell
[23]. The C2terminal domain of SpoT is thought to be
responsible for regulating this transition, however, the mechanism
of this regulation is not understood. We had shown that ACP
interacted with the C-terminal domain of SpoT, and that the
ACP/SpoT interaction was involved in controlling the stringent
response in response to fatty acid synthesis inhibition. These results
suggested a regulation of SpoT catalytic activities by ACP, which
may transduce the status of fatty acid metabolism in the cell to
SpoT [16].
In this first study, we had looked for mutations in SpoT
abolishing its interaction with ACP in order to study the role of the
interaction [16]. However, a more direct proof of the regulation of
SpoT by ACP would have been to find ACP mutants that did not
interact with SpoT but that were still functional for fatty acid
synthesis. We anticipated difficulties with this approach, due to the
small size of ACP, its essentiality, and to the fact that it interacts
with so many different enzymes for fatty acid synthesis. Yet,
meanwhile, it was shown in vivo that ACP can tolerate a lot of point
mutations [24]. Therefore, we decided to follow an approach of
random mutagenesis on ACP, by looking for mutations abolishing
specifically the interaction with SpoT. We aimed first at defining
what is the region of interaction with SpoT on ACP, and then to
characterize the physiological consequences of breaking the ACP/
SpoT interaction.
Results
Screen for ACP mutants unable to interact with SpoT
In order to select mutants of ACP that could not interact with
SpoT anymore, we used the bacterial two-hybrid technique that
proved successful to characterize the ACP/SpoT interaction
[16,25,26]. We performed random mutagenesis on the acpP coding
sequence and then cloned it in the pT18link plasmid. The
resulting library of pT18-ACP mutants was then screened by two-
hybrid against pT25-SpoT and clones that had lost the interaction
were selected (Materials and Methods). Expression of the
recombinant T18-ACP mutant proteins was then verified by
Western blotting using an antibody directed against the T18
domain. At this stage, more than half of the clones corresponded
to truncated T18-ACP proteins, due to the deletion of one
nucleotide caused by the mutagenesis process. We selected the
clones giving full-length T18-ACP proteins (Figure S1). These
clones were then sequenced (Table 1), and the loss of interaction
with SpoT was again verified and quantified by ß-galactosidase
assay (Figure 1 and data not shown).
We obtained 28 clones for which the interaction was lost
(Table 1). Among them, 11 clones contained the M44I mutation
and 1 the M44K mutation. Besides the mutants on methionine 44,
5 additional clones contained a single mutation, and 11 clones
contained 2, 3, or 4 mutations (Table 1). We discarded the
mutants containing 3 or 4 mutations, but we wanted to test further
the point mutations contained in the 4 clones containing two
mutations (ACP3, ACP16, ACP103, ACP57). Therefore, we
performed site directed mutagenesis on pT18-ACP plasmid in
order to clone the 8 corresponding single mutations independent-
ly, and we checked again if the ACP mutants interacted with
SpoT. This gave us 2 additional point mutants that did not
interact with SpoT (ACP745 and ACP749, Table 1; Figure 1).
Finally, the ACP87 clone containing the Thr64Ala mutation,
a deletion of the three last residues of ACP, and an unrelated C-
terminal 12 residues extension, was also selected due to its
interesting properties (see below).
In total, at this step, we selected 10 single point mutants that did
not interact with SpoT (ACP15, ACP18, ACP27, ACP68, ACP77,
ACP82, ACP132, ACP149, ACP745, ACP749) plus ACP87 for
further analysis (Table 1).
Screen for ACP mutants that are still functional for fatty
acid synthesis
The ACP mutants were screened for loss of interaction with
SpoT. Yet, we wanted to test the effect of losing specifically this
interaction, without losing essential interactions required for fatty
acid biosynthesis. Indeed, acpP is essential, due to its role in fatty
acid biosynthesis [27]. In order to test rapidly the functionality of
the ACP mutants, we tried to complement a strain that contains an
acpP
ts allele [26,27]. We first verified that the pT18-ACPwt
construct was able to complement the MG1655acpP
ts strain for
growth at 42uC (data not shown, [26]), and then tested the 11
clones selected above. Only the ACP15(M44I) mutant was clearly
able to complement MG1655acpP
ts for growth at 42uC (data not
shown). ACP68(V43E) and ACP132(L42M) mutants also comple-
ment to some extent as they allowed the formation of small
colonies at 42uC, but there was no further growth after subcloning
again at 42uC (data not shown). It has to be noted that the
MG1655acpP
ts strain is also deleted for the adjacent fabF gene. fabF
is not essential [27], but it cannot be excluded that its deletion
contributes to the defaults observed for the acpP mutants.
Furthermore, in this assay, the functionality of the ACP mutants
is tested at 42uC, while some mutants might prove to be
thermosensitive yet functional at lower temperatures. Finally, the
function of T18-ACP recombinant protein might already be non
optimal as compared with wild type ACP.
In order to get rid of all the problems just exposed, we had to
design a new genetic assay for getting a clear conclusion about the
functionality of the ACP mutants. We decided to assay the
possibility of P1 transduction of a DacpP::kana
R allele in strains
transformed with plasmids expressing the ACP mutants (this is
similar to an assay previously used for testing cyclic ACPs activity
[28]). The acpP gene with its wild type promoter sequence was
Figure 1. Bacterial two-hybrid assay between T25-SpoT and
the series of T18-ACP mutants. BTH101 strain was transformed by
pT25-SpoT (pEB595) and the series of pT18-ACP mutants isolated from
the mutagenesis screen on MacConkey plates, and corresponding to
full-length recombinant proteins. ß-galactosidase assay was performed
on 3 independent clones for each pair, as described in the materials and
methods.
doi:10.1371/journal.pone.0036111.g001
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MG1655 strain by the pKO3-acpP plasmid (pEB1334), and we
replaced the acpP ORF in this strain by a kanamycin resistance
cassette, giving strain MG1655DacpP::kana
R/pKO3-acpP (EB689).
The wild type MG1655 strain was then transformed by the pKO3-
acpP mutant plasmids. On these strains, the possibility to transduce
the DacpP::kana
R allele from EB689 strain was finally tested.
We obtained clones for the ACP15(M44I), ACP68(V43E),
ACP87(T64A+Ct), and ACP132(L42M) mutants, demonstrating
that they were functional for fatty acid synthesis (Table 1). We also
obtained clones for the ACP18(F50S) and ACP749(I54T) mutants,
yet they were severely affected in growth. As a negative control, we
verified that it was impossible to delete acpP in a strain transformed
with pKO3-acpP(S36T) coding for an ACP(S36T) mutant that
cannot be post-translationnally modified by 49-PP and is therefore
not functional.
We additionally confirmed the functionality of the ACP mutants
in vitro. We first purified them as 6His-Tev-ACP recombinant
proteins. Then, we tested their ability to be acylated with oleate
using purified acyl-ACP synthase Aas. The acylation state was
then analysed on SDS-PAGE, taking advantage of the aberrant
migration of ACP at an apparent molecular weight of 16 kDa on
this gel, which is restored to normal (11 kDa) upon acylation. As
a control, we used the 6His-Tev-ACP(S36T) protein mutated on
the reactive Serine 36 residue, which as a consequence cannot be
acylated. We verified that the 6 mutants were acylated by Aas
(Figure 2). However, the ACP(F50S) and ACP(I54T) mutants were
less effectively acylated than the others (about 85% acylation
compared to 25% for the wild type), consistent with the observed
growth phenotype of the corresponding mutant strains (see above).
Despite the small size of ACP and its essentiality, we were
therefore able to isolate 6 ACP mutants unable to interact with
SpoT, but still functional for fatty acid biosynthesis. Three of these
mutants had mutations that mapped in consecutive residues of a-
helix II: M44I, L42M, and V43E (Figure 3). The mutations in
ACP(F50S) and ACP(I54T) mutants located at the bottom of the
hydrophobic pocket (Figure 3). Finally, the last mutant carried
a T64A substitution together with a frameshift causing a deletion
of its 3 last residues replaced by a random C-terminal extension of
12 residues (noted ACP(T64A+Ct), Figure 3).
Confirmation of the loss of interaction with SpoT using
co-purification
The mutants were initially selected for their loss of interaction
with SpoT using the bacterial two-hybrid and the plasmid pair
pT25-SpoT/pT18-ACP. Yet, we wanted to check the presence or
absence of interaction by another technique than the two-hybrid.
Previously, the ACP/SpoT interaction was evidenced by affinity
co-purification of SpoT with ACP fused to the CBP tag
(Calmodulin Binding Peptide) on Calmodulin beads [16]. Yet,
we recently showed that the T18 domain of adenylate cyclase used
in the two-hybrid has also the property to bind calmodulin beads
in presence of calcium [30]. Therefore, we reasoned that we could
purify directly the various T18-ACP mutants on Calmodulin
beads and test if SpoT was co-purified with them.
Table 1. ACP mutants.
Clone number Mutation(s) Functionality
ACP3 D31Y-A45V nd
ACP15, 23, 44, 45, 52, 56, 59, 63, 88, 135, 140 M44I +
ACP16 G12C-A68D nd
ACP18 F50S +/2
ACP27 M44K 2
ACP50 L32P-T52S I69N nd
ACP57 D51G-I54T nd
ACP65 L15Q-K18R-L32P nd
ACP67 E5K-S36P-F50S-I69N nd
ACP68 V43E +
ACP77 K9T-G16S-I62N 2
ACP82 A34P 2
ACP87 T64A, DHQA, +12 residues +
ACP102 K8N-K9N-T23P-V65L nd
ACP103 D35G-P55Q nd
ACP132 L42M +
ACP148 D31G-T39I-A45D nd
ACP149 L32P 2
ACP745 A68D (from ACP 16) 2
ACP749 I54T (from ACP57) +/2
ACP(S36T) S36T 2
ACP mutants number 3 to 149 were obtained by random mutagenesis. Mutants ACP745 and ACP749 were obtained by site-directed mutagenesis. Mutant ACP(S36T)
was described previously [15]. Functionality corresponds to the result of the complementation test by transduction of the DacpP::kana
R deletion in strain MG1655
containing the pKO3-acpP mutant construction (see text). + indicates growth on LB plate equivalent to the growth of the wild type; -indicates that no clone was
obtained; +/2 indicates that colonies were obtained, but growth was severely delayed; nd (not determined) indicates that the corresponding ACP mutants were not
tested for functionality. The six mutants further characterized in the study are indicated in bold letters.
doi:10.1371/journal.pone.0036111.t001
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terminus by the SG tag (Streptag and IgG binding domains of
Protein G separated by the TEV cleavage site) [31]. This
permitted us to detect SpoT easily by Western blotting thanks to
the Protein G moiety, yet keeping its physiological expression. We
first verified that the interaction between T18-ACP and SpoT-SG
was detected by affinity purification on calmodulin beads. The
W3110/SpoT-SG strain (EB674) was transformed by pT18-ACP
and purification on Calmodulin beads was then performed
(Materials and Methods). SpoT-SG specifically co-purified with
T18-ACP as detected by Western blotting (Figure 4A). The
W3110/SpoT-SG strain was then transformed by the series of
pT18-ACP plasmids corresponding to the ACP mutants that did
not interact with SpoT, but that were still functional. Purification
on Calmodulin beads was then performed on extracts prepared
from each strain.
T18-ACP(F50S), ACP(V43E), ACP(T64A+Ct), and ACP(I54T)
did not pull down SpoT-SG (Figure 4A), consistent with the initial
two-hybrid screen. Surprisingly, SpoT-SG clearly co-purified with
T18-ACP(M44I) and T18-ACP(L42M) mutants (Figure 4A),
which were initially selected for the loss of interaction with T25-
SpoT in the bacterial two-hybrid test. In a last way of testing the
interaction, we transferred the ACP mutations from the pT18
plasmid to the pT25 plasmid and tested the reverse interaction by
two-hybrid against T18-SpoT. In this orientation, an interaction
was detected only for T25-ACP(M44I) and T25-ACP(L42M)
(Figure 4B), therefore giving the same result as the co-purification
experiment (Figure 4A). The results of these different tests are
summarized in table 2. These results indicated that we had isolated
two kinds of mutations provoking distinct effects on the interaction
with SpoT: the ones breaking the interaction as evidenced both by
two-hybrid and co-purification (F50S, V43E, T64A+Ct, I54T) and
Figure 2. In vitro acylation assay of purified ACP mutants. The indicated purified ACP mutants were assayed for acylation with oleate using
acyl-transferase Aas enzyme (see Material and Methods). ACP species were analyzed on a 15% SDS-PAGE stained with Coomassie Blue. Molecular
weight markers in kDa are indicated on the left-hand of the gel.
doi:10.1371/journal.pone.0036111.g002
Figure 3. Localization of the mutations in the functional ACP mutants. A. Multiple sequence alignment of selected ACP homologues. The 9
sequences of ACP from the indicated bacteria were aligned with ClustalW [43]. The secondary structure is shown above the alignment. The positions
of the mutated residues are indicated with green starts and the substitution is indicated below. The C-terminal extension present in the ACP(T64A,
DHQA, +12 residues) is shown in green at the right of the alignment. B. Ribbon representation of the 3D structure of ACP (PDB 1L0H; [5]) prepared
with the UCSF Chimera software [44]. The mutated residues in the different ACP mutants are coloured in green. The essential Ser36 residue, modified
by 49PP and required for ACP function, is highlighted. The acidic and basic residues are coloured in red and blue respectively.
doi:10.1371/journal.pone.0036111.g003
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one combination of the two-hybrid plasmids, and not as assayed
by co-purification (L42M and M44I). Because the two-hybrid
plasmids have very different copy numbers (much higher for pT18
than pT25), this result suggested that the effect of these two last
mutations depended on the stoichiometry of the partners, and
especially of SpoT. Indeed, in the co-purification experiment, only
SpoT-SG recombinant protein is produced, suggesting that
competition with endogenous SpoT might account for the
differences in the two-hybrid experiments. To test this hypothesis,
we performed the 2-hybrid assay of T18-SpoT against the T25-
ACP(L42M) and -ACP(M44I) mutants with or without over-
expression of wild type spoT in trans. The interaction between
SpoT and the two ACP mutants in this combination of plasmids
was indeed abolished when spoT was overexpressed (Figure S2).
We concluded from this experiment that in the T18-ACP/T25-
SpoT combination of plasmids used for the initial screen,
endogenous wild type SpoT might enter in competition with the
low amount of T25-SpoT, thereby increasing the negative effects
of the mutations. In the reverse combination (T18-SpoT/T25-
ACP), there is much more T18-SpoT produced, which may then
not be displaced by the endogenous SpoT.
ACP mutations also affect the interaction with other
partners of ACP
The mutations that affected SpoT interaction were likely to
affect also the interactions with other partners of ACP, even if not
abolishing totally its function. In order to test interactions with
various known partners of ACP, we used two techniques, affinity
co-purification and two-hybrid.
First, we used the exact same samples obtained from the
experiment of SpoT-SG pull down by T18-ACP (see above) in
order to test the interaction with MukB. This interaction was
previously described in the TAP purification of ACP [13]. MukB
was clearly identified in the T18-ACP purification (Figure 4A).
Only the T18-ACP(L42M) mutant also pulled down MukB
protein. In contrast, all the other ACP mutants were impaired in
their interaction with MukB (Figure 4A).
In parallel to the co-purification experiment, we tested if it was
possible to detect the interaction of ACP with its partner enzymes
in fatty acid biosynthesis by the bacterial two-hybrid technique.
We cloned nearly all the genes coding for fatty acid synthesis
enzymes in the pT25 plasmid and we systematically tested the
interaction with ACP. Only T25-FabZ, T25-FabA, and T25-PlsX
gave a robust and clear signal of interaction with ACP (Table 2).
Therefore, we screened the interaction of the ACP mutants with
these 3 proteins by two-hybrid. All the mutants were impaired for
the interaction with FabA and PlsX. They were also all affected for
the interaction with FabZ, excepted ACP(V43E).
Table 2 summarizes the results obtained by co-purification or by
two-hybrid experiments. Different profiles of interactions were
observed.ACP(F50S),ACP(T64A+Ct),andACP(I54T)mutantsdid
not interact with any partner tested. ACP(M44I) and ACP(L42M)
were still able to pull down SpoT-SG despite the loss of interaction
with T25-SpoT by two-hybrid. ACP(L42M) was the only one to
conserve the interaction with MukB and ACP(V43E) was the only
one to conserve the interaction with FabZ.
Phenotypes of the ACP mutants
It was surprising that mutants unable to interact with enzymes
of fatty acid biosynthesis were still able to sustain growth.
Figure 4. Interactions of the ACP mutants with SpoT and MukB.
A. Co-purification on calmodulin beads was performed as described in
Experimental procedures on extracts prepared from cultures of
W3110SpoT-SG transformed with the indicated pT18-ACP mutant
plasmids. Purified samples were analyzed by SDS-PAGE (10% for MukB
and SpoT-SG and 12% for T18-ACP) and Western blotting, with anti-T18
to detect the purified ACP mutants, an anti-MukB antibody [45] to
detect the wild type endogenous MukB, and finally PAP antibody to
detect the endogenous tagged SpoT protein. B. BTH101 strain was
transformed by pT18-SpoT (pEB596) and the pT25-ACP mutant
plasmids. ß-galactosidase assay was performed on 3 independent
clones for each pair, as described in the materials and methods.
doi:10.1371/journal.pone.0036111.g004
Table 2. Interaction profiles of ACP mutants.
Two-hybrid T25-
Two-
hybrid
T18- Co-purification
FabZ FabA PlsX SpoT SpoT
SpoT-
SG MukB
ACP +++++ + +
ACP(M44I) 2222++ 2
ACP(F50S) 22222 2 2
ACP(V43E) + 2222 2 2
ACP(T64A+Ct) 22222 2 2
ACP(L42M) 2222++ +
ACP(I54T) 22222 2 2
The two-hybrid interaction profiles have been obtained by assaying the
interaction between the T18-ACP mutants and the indicated T25- constructions
(first 4 columns), and also by assaying the T25-ACP mutants against T18-SpoT
(middle column; Figure 4B). The co-purification results correspond to the
experiment presented in figure 4A. The results obtained for the ACP/SpoT
interaction in the three different assays (2-hybrid against T18-ACP, 2–hybrid
against T25-ACP, and co-purification of SpoT-SG with T18-ACP on Calmodulin
beads) are indicated.
doi:10.1371/journal.pone.0036111.t002
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six MG1655DacpP/pKO3-ACP mutant strains. As observed on
plates, the ACP(F50S) and ACP(I54T) mutants grew very poorly
(Figure 5). ACP(V43E) and ACP(L42M) had a lower growth rate
than the wild type, while ACP(M44I) and ACP(T64A+Ct)
presented the same doubling time in log phase than the wild
type. Yet, the ACP(T64A+Ct) mutant presented the interesting
behaviour of entering the stationary phase later than the wild type,
and reaching a higher final OD600nm. This suggested that this
mutant was impaired in its response to the entry into stationary
phase. Furthermore, when we checked the morphology of the
cells, the ACP(T64A+Ct) cells in stationary phase were signifi-
cantly longer and bigger than the wild type (figure 6), here again
showing a failure in the stationary phase program.
The properties of the ACP87(T64+Ct) mutant were the most
interesting. Indeed, this ACP mutant protein did not interact with
any of the partners of ACP that we had tested (Table 2), yet the
corresponding mutant strain grew as well as the wild type.
However, it was also the only mutant strain that displayed
a morphological phenotype (Figure 6). We further dissected the
different mutations present in the ACP87(T64+Ct) mutant in
order to understand which mutation caused the loss of interaction
with SpoT and the growth phenotype. The ACP(T64A) mutation
alone or the deletion of the last 3 residues of ACP alone did not
affect the interaction with SpoT, nor the growth of the
corresponding mutant strains (Figure S3). In contrast, the random
extension of 12 residues caused by the frameshift was sufficient to
abolish the interaction with SpoT (Figure S3). However, appear-
ance of the growth and morphology phenotypes required the
presence of both the T64A substitution and the C-terminal
extension (Figure S3). These results suggest that the C-terminal
extension is the main factor affecting the ACP87(T64+Ct) mutant.
One of the goals of this study was to assess the physiological
consequences of breaking the ACP/SpoT interaction, especially
on the ability of SpoT to increase ppGpp levels in response to fatty
acid synthesis inhibition [16,22]. However, the mutants that we
have isolated were not specific for the interaction with SpoT.
Nevertheless, we decided to test the ability of the mutant strains
MG1655DacpP/pKO3-ACPwt, -ACP(T64A+Ct), -ACP(M44I), -
ACP(V43E), and -ACP(L42M) to synthesize ppGpp in response to
fatty acid synthesis inhibition triggered by the cerulenin antibiotic.
The four mutants were still able to synthesize ppGpp (Figure S4;
and data not shown). This suggested that the loss of SpoT
interaction as detected by 2-hybrid and co-purification might not
be sufficient to break the SpoT control by ACP, similarly as the
loss of several interactions with fatty acid synthesis enzymes was
not sufficient to break this synthesis pathway.
Discussion
There have been extensive studies on the role of specific ACP
residues in its folding and its interaction with fatty acid synthesis
enzymes (reviewed in [2,3]). These studies, performed in vitro,
permitted the prediction of the regions on ACP and on its partner
enzymes involved in the interactions. Only recently, the
functionality of ACP point mutants has been assayed in vivo
[24,27]. The present work brings this approach further, by looking
this time at the consequence in vivo of ACP mutations on its
interactions primarily with SpoT, but also with enzymes of fatty
acid synthesis.
In this study, we initially screened for point mutants of ACP
unable to interact with SpoT but still functional for fatty acid
biosynthesis, as judged by their ability to sustain growth. Three
consecutive mutations fulfilling these criteria mapped at the
middle of ACP helix II (Figure 3, ACP(M44I), ACP(V43E),
ACP(L42M)). This a-helix was already shown to be the site of
interaction of ACP with several of its enzyme partners in fatty acid
synthesis [2,8,9]. Furthermore, the few structures available of ACP
in complex with a partner enzyme (FabI, AcpS, YchM) also
highlight the importance of helix II in the contact [10–12].
However, the mutations not only broke the interaction with SpoT
but also abolished the interactions with enzymes involved in fatty
acid synthesis such a FabZ, FabA, and PlsX as judged by two-
hybrid experiments. These results indicate that ACP helix II is
similarly involved in SpoT recognition and in the recognition of
fatty acid synthesis enzymes. ACP is a highly acidic protein, and
Figure 5. Growth of the ACP mutant strains. Strain MG1665DacpP::kana
R complemented by the pKO3-acpP mutant series was grown overnight
at 30uC in LB containing Chloramphenicol. The cultures were then diluted 100X in LB containing Chloramphenicol and aliquots of 150 ml were grown
in a TECAN microplate reader at 30uC with continuous shaking. Note that the indicated OD600nm is 4 times lower than the usually OD measured with
a standard spectrophotometer.
doi:10.1371/journal.pone.0036111.g005
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surrounded by several acidic residues (Figure 3B). This helix is
expected to be responsible for the interaction with basic patches at
the surface of the partners of ACP [8]. The replacement of the
Methionine 44 residue by an Isoleucine residue had an
intermediate effect on the interaction with SpoT (table 2) and
did not produce any growth phenotype. On the contrary, its
replacement by the basic Lysine residues totally abolished ACP
function (mutant ACP27, table 1). Similarly, the replacement of
Leucine 42 by a Methionine had an intermediate effect on the
interaction with SpoT (table 2), and little growth phenotype. These
two point mutations correspond to the replacement of large
hydrophobic residues by other hydrophobic residues of similar
size. This suggests that the overall structure and function of ACP is
not affected, but that recognition of SpoT and the fatty acid
synthesis enzymes is weakened, consistent with this region being
responsible for the recognition of ACP partners. As expected, the
mutation of the smaller hydrophobic Valine 43 in a Glutamic acid
had more drastic consequences. The interactions were abolished
in all the different assays that we have performed (table 2), and
a consistent growth phenotype was observed (figure 5). In this case,
we can assume that the structure of helix II is more destabilized,
hence affecting both the function of ACP and the recognition of its
protein partners.
The three residues LVM in a-helix II are mostly conserved in
bacteria, except in ACP of S. pneumoniae (Figure 3A), whereas SpoT
is found only in ß- and c-proteobacteria. Furthermore, mutations
in these three residues similarly affect the interaction with SpoT
and with fatty acid synthesis enzymes. This suggests that the
specificity of the ACP/SpoT interaction has to be found in SpoT,
rather than in ACP. The recognition by the acidic ACP protein of
basic patches at the surface of its enzyme partners [8] is consistent
with the overall basic nature of SpoT. However, there is no
evident enriched cluster of basic residues on this big (702 residues)
and complex protein that can be identified without further
information. We previously showed that the TGS domain of SpoT
is involved in the interaction with ACP [16]. However, this region
is no more basic than the rest of the protein. In ß- and c-
proteobacteria, there are two homolog proteins SpoT and RelA
that originated from the duplication of an ancestral Rsh protein
[32]. We showed that ACP interacted with SpoT, but not with
RelA. Yet, when we replaced the TGS domain of SpoT by the
TGS domain of RelA, the interaction with ACP was maintained
[16]. This showed that the TGS itself, although necessary for the
interaction, is not the determinant of the specificity of the
interaction with ACP, and that other regions of SpoT must be
involved. The recently published phylogenetic study of the RelA/
SpoT homolog family will help us to decipher the specificities of
SpoT that might account for ACP recognition [32].
The residues mutated in ACP(F50S) and ACP(I54T) mutants
localize at the bottom of the hydrophobic pocket, and are
important for the folding of ACP and the contact with the fatty
acid chain buried in ACP [33]. The corresponding mutant strains
are viable, yet their growth is drastically slowed down compared to
the wild type strain, and the purified proteins are poorly acylated
in vivo (Figures 2 and 5). Furthermore, all the interactions with the
partners of ACP that we tested were abolished (Table 2). These
two residues are absolutely conserved, not only in bacteria
(Figure 3A) but also in very distant ACP-like domains that
participate in polyketide synthase reactions (See sequence align-
ments in [24] and in [2]. Consistently, it has been shown that these
2 residues are crucial for maintaining ACP stability [24,34].
Furthermore, Isoleucine 54 has been implicated in several
interactions [9,10,35]. In conclusion, the effect of these two
mutations on ACP function and on its interaction with SpoT more
probably result from a global destabilisation of ACP, and these two
residues do not define a specific region for SpoT interaction.
ACP(T64A+Ct) mutant is a special case. In addition to the
T64A substitution, it lacks the three last residues of ACP and
carries a C-terminal extension, which we showed to be the main
determinant of the phenotypes (Figure S3). Despite the total loss of
all the interactions tested, it is completely functional. ACP is
known to tolerate N-terminal, C-terminal tagging, and even
cyclization of its extremities [28]. Yet, despite an initial wild type
growth rate during exponential phase, ACP(T64A+Ct) mutant
displays a defect in growth regulation as shown by its delayed entry
into stationary phase and morphological default. We propose that
the C-terminal extension might prevent conformational changes
involved in regulation of growth, maybe important for the
detection by regulatory proteins such as SpoT.
There is a high degree of sequence conservation between
bacterial ACPs involved in fatty acid synthesis (38% identity and
60% similarity for the most distant ACP from S. pneumoniae for
example), with the DSL signature encompassing the Serine residue
modified by the 49PP group being absolutely conserved
(Figure 3A). This reflects the evolutionary constraints imposed
on this protein that must interact with so many distinct enzymes.
Accordingly, ACPs from various bacterial species can complement
an E. coli mutant [24,26]. Yet, we obtained several mutants in
conserved residues that were still functional. It has to be noted that
our results on residues V43 and I54 are in accordance with
a systematic functional analysis of ACP mutants in vivo published
Figure 6. morphology of the ACP mutant strains. Strain
MG1665DacpP::kana
R complemented by the pKO3-acpP mutant series
was grown overnight at 30uC in LB containing Chloramphenicol. The
cultures were then diluted 100X in 3 ml of LB containing Chloram-
phenicol. At OD600nm=0.5 (A) and after overnight growth (B), the
cultures were observed by phase contrast microscopy with a 100X
objective.
doi:10.1371/journal.pone.0036111.g006
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the functionality of the ACP mutants, there was a loss of
interaction with essential enzymes of fatty acid synthesis. We have
assessed the functionality of the mutants for fatty acid synthesis by
their ability to sustain growth in vivo, but also by their ability to be
acylated in vitro (Figure 2). This suggests that a limited but sufficient
recognition must occur between the ACP mutants and the fatty
acid synthesis machinery, but which is not detected by the
techniques used to test the interactions.
Clearly, these methods for studying protein-protein interactions
showed variation in their sensibility. Despite the first selection for
loss of interaction by two-hybrid, the co-purification experiments
indicated that the interaction with SpoT is maintained for
ACP(M44I) and ACP(L42M) mutants, as it was the case for the
reverse two-hybrid experiment (Figure 4). For the co-purification
experiments, this discrepancy might be explained by the fact that
the interactions with ACP are often maintained by disulphide
bridges when the cells are broken, as it was reported before
[13,36,37]. This stabilization would not happen in the two-hybrid
interactions that are detected in vivo, explaining the higher
sensitivity of this last method to a weakened interaction. In the
case of the two combinations of the two-hybrid plasmids, using
a competition experiment, we showed that the difference might
result from a dependence of the interaction on the stoichiometry
between ACP and SpoT and the competition with endogenous
SpoT wild type protein (Figure S2). Moreover, the interactions
between ACP and its partners are intrinsically weak, because they
must be reversible in order to interact and recognize many
different enzymes [6]. For fatty acid synthesis, the main de-
terminant of recognition is ultimately the specific substrate of the
enzyme bound to the 49PP group on ACP. The 2-hybrid or co-
purification techniques might reflect only the weak and easily
broken protein-protein interactions, whereas recognition of the
substrate might be sufficient for essential enzymatic steps to occur.
The same may apply for the recognition of ACP by SpoT, which is
also expected to recognize a specific fatty acid molecule bound to
ACP that transduces the information about fatty acid synthesis
inhibition to SpoT [16]. This would explain why the ACP mutants
are still able to synthesize ppGpp in response to fatty acid synthesis
inhibition (Figure S4 and data not shown), as they were also still
able to sustain fatty acid synthesis.
It has to be noted that we have used in this study a nearly
physiological assay for the functionality of ACP mutants in vivo
(Figure S5). Indeed, we have used a low copy plasmid ensuring the
expression of acpP from its natural promoter, without the need for
artificial expression. This proved to be important, considering the
different results obtained when we tried to complement an acpP
ts
strain with the high copy number pT18 plasmids (data not shown).
The effect of ACP amounts on its function in vivo has already been
reported [24]. Furthermore, our genetic assay ensures the absence
of undesired recombination because the chromosomal copy of
acpP is completely deleted, and there is no need to grow the cells at
high temperature, which permits the study of mutants that might
be thermosensitive.
In conclusion, in the light of the initial goals of our study, we
were able to determine that helix II of ACP is involved in the
recognition of SpoT, by mechanisms similar to the interaction of
ACP with enzymes of fatty acid synthesis. Unfortunately, as
a consequence, it appeared impossible to specifically break the
interaction with SpoT without affecting the recognition of the fatty
acid synthesis system. Therefore, it is difficult to assess the
physiological consequences of breaking specifically the ACP/SpoT
interaction. Yet, we found an ACP mutant that displayed growth
regulation phenotypes, confirming our previous hypothesis that
lipid metabolism is an important cue in bacterial growth control,
as is ppGpp and the stringent response. Further work will be
important in order to understand what are the mechanisms of
growth control affected in this mutant.
Materials and Methods
Media and growth
Cells were grown in Luria-Bertani (LB) medium [38] at 30uCo r
37uC as specified in the text. Plasmids were maintained with
ampicillin (100 mg/ml), chloramphenicol (30 mg/ml), or kanamy-
cin (50 mg/ml). MacConkey plates contained 50 g/L Difco
TM
MacConkey agar powder plus ampicillin (100 mg/ml), kanamycin
(50 mg/ml) and 1% maltose.
Plasmids
Plasmids are listed in Table 3. pT18-ACP (pEB379) and pT25-
SpoT (pEB595) plasmids used for testing the interaction between
ACP and SpoT by bacterial two-hybrid have been described
previously [16]. The other two-hybrid plasmids have been
constructed by inserting the ORF sequences in pT18 and pT25
plasmids [15], using the oligonucleotides indicated in Table S1.
The acpP mutant alleles were transferred from the pT18-ACP
mutated plasmids to the pT25link plasmid using EcoRI and XhoI
restriction sites. Plasmid pCTAP(SG) (pEB1142) was constructed
by replacing the TAP tag from pJL148 [39] by the SG tag [31].
pKO3-acpP plasmid (pEB1334) was constructed by inserting the
acpP ORF and the 460 upstream base pairs in the pKO3 low copy
plasmid [29] using BamHI and SalI restriction sites. The pKO3-
acpP mutant plasmids were obtained by site directed mutagenesis
on pKO3-acpP using the Quickchange kit from Stratagene, for
ACP15, ACP68, and ACP132 using the oligonucleotides indicated
in table S1. The other mutations were transferred in pKO3-acpP
by overlapping PCRs: 59UTR of acpP was amplified with
Ebm133/136, the acpP ORF containing the mutations was
amplified with Ebm135/77, and a second PCR performed on
these two first PCRs was performed with Ebm133/77 and cloned
back in pKO3 (BamHI/SalI). pET-6His-Tev-acpP plasmid
(pEB1154) and the mutant derivatives were constructed by
transferring the acpP ORFs in the pET-6His-Tev plasmid
(pEB1188) [40] using EcoRI and XhoI restriction sites.
Strains
All strains used are derivatives of E. coli K12 and are listed in
table 4. The cya strain BTH101 [25] was used for the two-hybrid
assay. The MG1655acp
ts strain (EB341) was used to test the
functionality of the T18-ACP recombinant proteins [26]. Strain
MC4100 was used for testing T18 tagged protein expression.
Finally, strain C600 was used for plasmid constructions.
W3110/SpoT-SG strain was constructed by recombining the
SG tag sequence downstream spoT gene using pCTAP(SG)
(pEB1142) plasmid and the Datsenko and Wanner method [41].
MG1655DacpP::kana
R/pKO3-acpP strain was obtained by trans-
forming MG1655 by pKO3-acpP and pKD46 and then deleting
the chromosomal copy of acpP by recombination. The various acpP
mutant strains were then constructed by introducing the
DacpP::kana
R mutation in MG1655 strain transformed by the
various pKO3-acpP mutants using generalized P1 phage trans-
duction. The deletion of the acpP allele in the resulting MG1655/
pKO3-acpP mutant strains and the absence of duplication events
were verified by PCR (Figure S6). We also checked by PCR and
sequencing that the plasmids themselves were unchanged. The
amount of ACP protein produced in this strain was compared with
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ACP-TAP tagged clone and strain (see Figure S3).
Bacterial two-hybrid
After co-transformation of BTH101 strain [25] with the two
plasmids expressing the T18- and T25- fusions, LB plates
containing ampicillin and kanamycin were incubated at 30uC
for 2 days. 3 ml of LB medium supplemented with ampicillin,
Table 3. Plasmids.
Lab code BTH101number Name Description Reference
pEB0354 pT25link Kana
R, p15A ori, Plac, T25 [15]
pEB0375 pT25-ACP Kana
R, p15A ori, Plac, T25-acpP [16]
pEB0595 pT25-SpoT Kana
R, p15A ori, Plac, T25-spoT [16]
pEB1221 pT25-FabZ Kana
R, p15A ori, Plac, T25-fabZ This work
pEB0721 pT25-FabA Kana
R, p15A ori, Plac, T25-fabA This work
pEB0861 pT25-PlsX Kana
R, p15A ori, Plac, T25-plsX This work
pEB0355 pT18link Amp
R, ColE1 ori, Plac, T18 [15]
pEB0379 pT18-ACP Amp
R, ColE1 ori, Plac, T18-acpP [15]
pEB0596 pT18-SpoT Amp
R, ColE1 ori, Plac, T18-spoT [16]
pEB0999 pACYC-PBAD-spoT Cam
R, p15A ori This work
pEB1188 pET-6His-Tev Amp
R, T7 promoter, 6His-Tev N-terminal tag [40]
pEB1154 pET-6His-Tev-ACP acpP PCR Ebm76/77 in pEB1188(EcoRI/XhoI) This work
pEB0817 pET28-Aas-6his [42]
pEB1123 pCEMM-CTAP(SG) AmpR, ColE1 ori, CTAP(SG) tag [31]
pEB0794 pJL148 SPA-FRT-kanaR-FRT [39]
pEB1142 pCTAP(SG) TAP(SG)-kanaR-FRT This work
pEB0270 pKD13 Amp
R, FRT-flanked Kana
R [41]
pEB0267 pKD46 R101 ori (ts), Amp
R, lambda Red genes [41]
pEB0232 pKO3 repA(ts) ori, Cam
R, M13 ori, sacB [29]
pEB1334 pKO3-acpP acpP PCR Ebm133/77(BamHI/XhoI) in pKO3(BamHI/SalI) This work
pEB1369 pKO3-acpP(S36T) S36T mutagenesis on pEB1334 This work
ts: thermosensitive replication; Amp
R: carrying resistance to Ampicillin gene, Kana
R; carrying resistance to Kanamycin gene; Cam
R: carrying resistance to
Chloramphenicol. ori: origin of replication; FRT: recombination site for Flipase. The plasmids containing the mutations in acpP are not listed. They correspond to
mutagenesis of pEB379, pEB375, pEB1154, and pEB1334 plasmids.
doi:10.1371/journal.pone.0036111.t003
Table 4. E. coli K12 strains.
Lab code
BTH101number Name Description Reference
– MG1655 F
- l
- ilvG- rfb-50 rph-1 [46]
– C600 F
- tonA21 thi-1 thr-1 leuB6 lacY1 glnV44 rfbC1 fhuA1 l
- [46]
– W3110 F
- l
- INV(rrnD, rrnE) rph-1 [46]
EB003 BTH101 F- cya-99 araD139 galE15 galK16 rpsL1(Str
R) hsdR2 mcrA1 mcrB1 relA1 [25]
EB341 MG1655 acpP
ts acpP
ts DfabF::cam
R [26]
EB674 W3110/SpoT-SG spoT-SG-FRT-kana
R-FRT This work
EB689 MG1655DacpP pKO3-acpP MG1655DacpP::kana
R + pEB1334 This work
EB724 MG1655DacpP pKO3-acpP(M44I) MG1655DacpP::kana
R + pEB1365 This work
EB725 MG1655DacpP pKO3-acpP(F50S) MG1655DacpP::kana
R + pEB1370 This work
EB726 MG1655DacpP pKO3-acpP(V43E) MG1655DacpP::kana
R + pEB1360 This work
EB727 MG1655DacpP pKO3-acpP(T64A+Ct) MG1655DacpP::kana
R + pEB1377 This work
EB728 MG1655DacpP pKO3-acpP(L42M) MG1655DacpP::kana
R + pEB1362 This work
EB729 MG1655DacpP pKO3-acpP(I54T) MG1655DacpP::kana
R + pEB1391 This work
Ts: thermosensitive. Kana
R; carrying resistance to Kanamycin gene; Cam
R: carrying resistance to Chloramphenicol. FRT: recombination site for Flipase.
doi:10.1371/journal.pone.0036111.t004
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30uC overnight. ß-Galactosidase activity was determined as
described [38]. The values presented are the mean of 3 or 4
independent assays.
acpP mutagenesis
We performed random mutagenesis on the acpP gene ORF
using the GeneMorph II Random Mutagenesis Kit from
Stratagene with oligonucleotides Ebm76/77. The PCR was then
cloned in the pT18link (pEB355) plasmid [15] using EcoRI and
XhoI restriction sites. Strain BTH101 already transformed by
pT25-SpoT was transformed by the resulting library of pT18-ACP
mutants, and plated on LB plates containing Ampicillin and
Kanamycin. After 2 days at 30uC, colonies were replicated on
MacConkey petri dishes and again incubated 2 days at 30uC.
Minipreps of DNA were prepared from the white colonies and
used to transform an MC4100 strain in order to reisolate the
pT18-ACP mutant alone. A new two-hybrid assay was performed
between the isolated T18-ACP mutant and T25-SpoT in BTH101
strain in order to verify the loss of interaction. Then the expression
of the recombinant T18-ACP mutant proteins was verified by
Western blot using the 3D1 antibody directed against the T18
domain. Clones giving full-length T18-ACP proteins were
sequenced and kept for further analysis.
In vitro acylation assay of purified ACP mutants
6His-Aas was purified as described before using the pET28-Aas-
6his plasmid [42]. All the ACP mutants were purified as 6His-Tev-
ACP recombinant proteins, as described before [40]. The
acylation reaction (100 mM Tris pH 8, 5 mM DTT, 10 mM
ATP, 10 mM MgSO4, 100 mg/ml oleate, 2 mg ACP proteins, and
0.5 mg 6His-Aas in a final volume of 20 ml) was incubated 1 hour
at 37uC. The ACP species were then analyzed on a 15% SDS-
PAGE stained with Coomassie Blue. In this gel, acylated ACP
proteins migrate faster than the holo-ACP.
Co-purification on Calmodulin beads
From a 200 ml culture grown at 37uC in LB and induced
during 120 min with 0.5 mM IPTG to a final OD600 of
approximately 2, an extract was prepared by sonication in 7 ml
Calmodulin Binding Buffer (10 mM Tris-HCl pH 8.0, 150 mM
NaCl, 0,1% NP40, 1 mM Mg-acetate, 1 mM imidazole, 2 mM
CaCl2,) with 0.75 mM PMSF. After centrifuging 30 min at
27000 g, glycerol was added to 15% final concentration and the
extract was frozen in liquid nitrogen. For each co-purification
assay, 3 ml of extract were incubated on 40 ml of Calmodulin
beads previously washed in Calmodulin Binding Buffer. After
60 min of incubation at 4uC, the beads are washed fives times in
1 ml of Calmodulin binding buffer, resuspended in 40 mlo f
Laemmli loading buffer, and heated 5 min at 96uC.
SDS-PAGE and western blot
SDS-PAGE, electrotransfer onto nitrocellulose membranes, and
Western-blot analyses were performed as previously described
[13]. SG tag was detected with the PAP antibody from Sigma.
Monoclonal anti-T18 3D1 was purchased from Santa Cruz.
Supporting Information
Figure S1 Production of the T18-ACP mutant proteins.
Strain MC4100 was transformed with the indicated pT18-ACP
mutants. After induction for 3 h with 0.5 mM IPTG in LB
medium at 37uC, the recombinant proteins were detected by
Western blotting on a 10% SDS-PAGE using anti-T18 mono-
clonal antibody (3D1-Santa Cruz).
(PDF)
Figure S2 Competition assay of the interaction between
T18-SpoT and the T25-ACP mutants: Strain BTH101 was
transformed with pT18-SpoT (pEB596) and the indicated pT25-
ACP plasmid (pEB375 and its mutant derivatives), together with
the third pACYC-PBAD-SpoT plasmid (pEB999, +) or the control
pACYC184 (2). Cultures were grown overnight at 30uCi nL B
supplemented with ampicillin, kanamycin, chloramphenicol,
0.5 mM IPTG to induce the expression from the 2-hybrid
plasmids, and 0.5% arabinose to induce expression of spoT in
trans from the pACYC-PBAD-SpoT plasmid. ß-Galactosidase
activity was determined as described [38]. The values presented
are the mean of 3 independent assays.
(PDF)
Figure S3 Dissection of the mutations in the ACP(-
T64A+Ct) mutant. A. Interaction with SpoT. The T64A
substitution, the C-terminal extension, and the deletion of the last
3 residues of ACP were separated in three new T18-ACP
constructions and assayed for interaction with T25-SpoT. B.
Growth of the mutant strains. The same mutations were
introduced in pKO3-acpP plasmid and the corresponding mutant
strains were constructed by P1 transduction of the DacpP::kana
R
allele. The growth of the mutant strains was followed at 30uCi n
a TECAN microplate reader.
(PDF)
Figure S4 (p)ppGpp synthesis assay in response to fatty
acid synthesis inhibition by cerulenin. (p)ppGpp was
measured accordingly to [16]. In brief, cultures in low-phosphate
medium of the EB689 and EB727 strains were continuously
labeled for at least two generations with 100 mCi of [
32P]ortho-
phosphate per ml starting at DO600=0.05. Cerulenin was then
added at a final concentration of 200 mg.ml
21, and 20 mlo f
samples were taken at time 0, 3, 8, 15, 30, and 45 minutes.
Samples were immediately mixed with 20 ml of 16 M formic acid
on ice. 5 ml of the acid formic extracts were chromatographed in
one dimension on 20610 cm polyethyleneimine cellulose TLC
plates (JT Baker). TLC plates were developed using a FLA5100
Fuji phosphorimager.
(PDF)
Figure S5 Comparison of the amount of ACP-TAP
protein in strains MG1655/ACP-TAP and
MG1655DacpP::kana
R complemented by pKO3-acpP-
TAP. A, C: MG1655/ACP-TAP (EB657); B, D:
MG1655DacpP::kana
R/pKO3-acpP-TAP (pEB767). For each
strain, cultures in 20 ml LB containing ampicillin (100 mg/ml)
were incubated at 30uC with agitation for 5 h (DO600 A=1.6 and
DO600 B=1) and 24 h (DO600 C=6 and DO600 D=6.7). Cells
were pelleted by centrifugation and total cell extracts were
analyzed on a 10% SDS-PAGE followed by Western-blot with
PAP antibody (Sigma).
(PDF)
Figure S6 Control of the DacpP::kana
R deletion in
MG1655/pKO3-acpP mutant strains. The transduction of
the DacpP::kana
R allele in the MG1655/pKO3-acpP mutant strains
was verified by PCR on colonies using oligonucleotides ebm220/
ebm710. Amplification of a fragment of 1510 bases pairs indicates
that strains have acquired the DacpP::kana
R allele; amplification of
411 pb fragment indicates strains carrying the wild type acpP locus.
Ebm220: 59- ATTTTATACACTACGAAAACCATCGCG -
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GACG -39.
(PDF)
Table S1 Oligonucleotides used in this study.
(PDF)
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